The lawsuit escalates the pharmaceutical industry’s fight to rein in the federal drug-discount program known as 340B. The ...

The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective immunoproteasome inhibitor ...

Medical experts who’ve studied the experimental treatment program, however, say there’s no evidence to support Trump’s claims ...

Johnson & Johnson files suit against HHS over 340B program, proposing hospitals pay full price upfront for drugs and receive ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

the agency has placed a partial hold on a mid-stage trial of the drug in autoimmune hepatitis, Kezar said Tuesday in its Q3 ...

In blue and red states, voters rejected these industry-backed proposals, favoring policies that prioritize public health and ...

The dual-mechanism drug targets ULBP6, which is secreted by tumor cells and ... The company previously announced results from ...

In an exciting development for drug development and patient care, the FDA has officially accepted the first submission of an organ-on-a-chip technology under its Innovative Science and Technology ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Former President Donald Trump has boasted in recent months about "Right to Try," a law he signed in 2018. It’s aimed at boosting terminally ill patients’ access to potentially life-saving medications ...